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S U M M A R Y
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease in six epidemic
provinces of China and was identiﬁed to be caused by a novel bunyavirus in 2009. It is progressive in
nature and potentially fatal. SFTS usually occurs as sporadic cases and is considered a tick-transmitted
disease. Here we present a group of three patients with proven SFTS and one with probable SFTS, for
whom the epidemiological data show person-to-person transmission characteristics. The index patient
and two secondary patients died. None reported a tick bite.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
From 2007 to date, hundreds of cases of a fever, thrombocyto-
penia, and leukopenia syndrome have been reported in six
provinces of China, including Hubei.1 This is an emerging
infectious disease that has been named severe fever with
thrombocytopenia syndrome (SFTS) and is caused by a new type
of bunyavirus, called SFTS bunyavirus (SFTSV).1,2 SFTS usually
occurs as sporadic cases, and clustered cases occur less frequently.
We report a cluster of SFTS cases of human-to-human
transmission caused by the SFTSV that occurred in a hilly village
of Hubei Province between May and June in 2012. The index
patient presented the typical fever, thrombocytopenia, and
leukopenia and was hospitalized, but unfortunately he died. After
his death, three secondary patients successively became ill at 7–12
days after contact or exposure to the index patient’s blood and/or
bloody secretions. All three secondary patients had laboratory-
conﬁrmed diagnoses.
2. Case reports—clinical features and epidemiology
The index patient was a 63-year-old man who had a sudden
onset of fever on May 6, 2012, with a temperature of 39.3 8C,
accompanied by chills, pharyngeal pain, nausea, vomiting, and
abdominal pain. Routine blood tests showed leukopenia and* Corresponding author.
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platelets 87  109/l). He was admitted to the Department of
Hematology of the local hospital on May 7, and was administered
ribavirin, cefuroxime, and human granulocyte colony-stimulating
factor-stimulated clone. A non-contrast high-resolution computed
tomography scan of the abdomen showed no abnormal ﬁndings.
Obvious proliferation of nucleated cells and megakaryocytes with
65.0% of granulocytes was found on bone marrow cytology.
However, no clinical improvement was observed and melena and
generalized myalgia developed. There was no response to a series
of strategies, including broad-spectrum antibiotics, granulocyte
colony-stimulating factor therapy, and blood platelet and human
immunoglobulin infusion. The gastrointestinal bleeding persisted
and his platelet count and WBC count declined progressively. On
day 6 after the onset of fever, the WBC count had decreased to
1.19  109/l and platelets to 40  109/l. The patient was in a deep
coma and occasionally had convulsions. His skin was bleeding.
Tracheal intubation and invasive mechanical ventilation was
performed. Even so, resuscitation therapies were not effective. His
relatives did not want the patient to die in hospital and returned
him to his hometown with the endotracheal intubation and
intravenous infusions in place. Half an hour after arriving home,
the index patient died. This was on May 12, at day 7 after the onset
of the disease. Although he had typical clinical SFTS symptoms
including fever, thrombocytopenia, and leukopenia, the SFTS
diagnosis was not made.
After his death, his two brothers (case 1 and case 2) did his
make-up without taking any protective precautions. Case 1
removed his tracheal tube and case 2 withdrew his intravenousses. Published by Elsevier Ltd. All rights reserved.
Table 1
Clinical features of a cluster of severe fever with thrombocytopenia syndrome patients
Index patient Case 1 Case 2 Case 3
General data
Sex Male Male Male Female
Age, years 63 66 61 59
Date of onset May 6, 2012 May 23, 2012 May 19, 2012 May 24, 2012
Outcome Death Death Death Discharge
Date of death or discharge May 12, 2012 May 28, 2012 June 1, 2012 June 6, 2012
Length after onset, days 7 7 13 14
Symptoms and signs
Maximal temperature, 8C 39.6 40.2 40.6 39.8
Nausea and vomiting Yes No Yes No
Bleeding Yes Yes Yes Yes
Abdominal pain Yes No Yes No
Diarrhea Yes No No Yes
Malaise Yes Yes Yes Yes
Confusion Yes Yes Yes No
Conjunctival congestion Yes Yes Yes No
Lymphadenopathy Yes No No No
Laboratory ﬁndings
Platelets, 109/l
Onset 104 47 65 74
Min 40 28 13 48
White blood cell count, 109/l
Onset 1.39 1.69 2.65 2.69
Min 1.11 1.06 1.48 2.02
Alanine aminotransferase, U/l 326 289 646 136
Aspartate aminotransferase, U/l 543 257 340 184
Total protein, g/l 65.10 70.10 68.30 74.50
Albumin, g/l 29.30 35.20 28.40 33.20
Blood urea nitrogen, mmol/l 5.33 5.99 5.30 3.90
Creatinine, mmol/l 57.42 67.90 78.22 68.40
Lactate dehydrogenase, U/l 2022 1207 1578 605
Creatine kinase, IU/l 2113 729 326 106
Creatine kinase-MB fraction, ng/ml 15.42 54.57 12.65 2.15
Ultra-sensitivity cardiac troponin I, ng/ml 2.13 >50.00 1.65 0.10
Myoglobin, mg/l 243.33 >1000.00 189.52 172.74
N-terminal pro-brain natriuretic peptide, pg/ml 403.30 1165.70 786.60 325.80
Activated partial thromboplastin time, s 101.2 125.20 63.5 87.1
D-dimer, mg/l 49.92 29.40 9.03 8.63
C-reactive protein, mg/l 14.10 25.00 23.40 13.60
Procalcitonin 0.67 0.96 1.22 0.51
Multiple organ dysfunction syndrome Yes Yes Yes No
Hematuriaa +++ ++ ++ +
Proteinuriaa +++ ++ ++++ +
Virus isolation No data Yes Yes Yes
Real-time RT PCR No data Positive Positive Positive
RT-PCR, reverse transcriptase polymerase chain reaction.
a Possible results are: , negative; +, weak positive; ++, positive; +++, strong positive.
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blood or bloody secretions in the airway during this process. Case 3
came into contact with the index patient’s bloody secretions while
helping to clean his bloody clothes. The three cases successively
fell ill, with onset 7–12 days after exposure. They were admitted to
three different departments in three hospitals. Two of the cases
died (case 1 and case 2).
Due to the clustering of cases in this outbreak in the same village,
and with all cases having typical clinical symptoms including fever,
thrombocytopenia, and leukopenia (Table 1), there was a high
suspicion of SFTS. Blood samples from all of the secondary cases
were sent to the Hubei Province Center for Disease Control and
Prevention. The three secondary patients had laboratory-conﬁrmed
SFTS diagnoses by real-time reverse transcriptase polymerase chain
reaction (RT-PCR) and virus isolation. The index patient was not
analyzed for the pathogen because of misdiagnosis and the lack of a
serum sample. The clinical features of the index patient and three
secondary patients are listed in Table 1.
After 3 months of follow-up, no persons who took protective
precautions and who had been in contact with the patients,
including the three intensive care unit (ICU) doctors (working inthree different hospitals) performing intubations and 21 nurses,
had become ill. Fifty-eight other individuals who had been exposed
to the index patient from the onset of the illness until his funeral
ceremony, but who had not directly touched his secretions, had not
become ill. Also, no new case occurred in the 223 other inhabitants
of the same village.
3. Discussion
We have presented a group of three patients with proven SFTS
and one with probable SFTS, for whom epidemiological data
show person-to-person transmission characteristics. No tick bite
was reported by any of them. Although the index case had typical
SFTS features, he was not analyzed for the pathogen because of
misdiagnosis and the lack of a serum sample. Two of his brothers
and a neighbor successively became ill and were conﬁrmed as
having SFTS by etiological diagnosis, having come into contact
with his blood or secretions. His brothers died. After 3 months of
follow-up, no patients with SFTS were identiﬁed in those who
had been exposed to the patients but who had not directly
touched their secretions. No SFTSV was identiﬁed on real-time
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samples collected from 13 exposed relatives and neighbors, 42
medical staff (including the three ICU doctors and 21 nurses), or
patients staying in the same rooms. Also, no new case occurred in
the 223 other inhabitants of the same village.
The clinical diagnosis and differential diagnosis of this newly
recognized disease are of great importance. SFTS needs to be
differentiated clinically from other infectious diseases, such as
human anaplasmosis, hemorrhagic fever with renal syndrome, and
leptospirosis.1 The symptoms of SFTS were nonspeciﬁc. The key
clinical features include fever, thrombocytopenia, gastrointestinal
symptoms, leukocytopenia, and multiple organ dysfunction
syndrome (MODS).1 The most common abnormalities on labora-
tory testing were thrombocytopenia and leukocytopenia. WBC and
platelet counts may progressively decrease. MODS can develop
rapidly in severe cases and become the cause of death. In this
group, all four patients were misdiagnosed and were admitted to
four different departments, including hematology, cardiology,
gastrointestinal surgery, and respirology.
The transmission route of SFTS remains unclear. An impor-
tant question is whether SFTSV can be transmitted from person
to person. There is some epidemiological and molecular
evidence of person-to-person transmission of the virus.3–5 It
is speculated that the acute-phase serum samples and cadaveric
blood and bloody secretions are contagious. Persons who come
into direct contact with blood or bloody discharge can beinfected with SFTSV. Based on our data, all three secondary cases
had possible blood contact through unprotected skin and
mucosa, and hence we conclude that SFTSV can be transmitted
from human-to-human through contact with the patient’s
cadaveric blood or bloody secretions. This also indicates that
SFTSV-infected blood may remain infectious for a long time,
even after patient death.
More emphasis should be given to this disease and further
training of medical personnel should be carried out to prevent
misdiagnosis, especially in epidemic areas.
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